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Abstract
Hyaline cartilage and mechanically inferior fibrocartilage consisting of mixed collagen types are frequently found together
in repairing articular cartilage. The present study seeks to develop methodology to identify collagen type and other tissue
components using Fourier transform infrared (FTIR) spectral evaluation of matrix composition in combination with
multivariate analyses. FTIR spectra of the primary molecular components of repair cartilage, types I and II collagen, and
aggrecan, were used to develop multivariate spectral models for discrimination of the matrix components of the tissues of
interest. Infrared imaging data were collected from bovine bone, tendon, normal cartilage, meniscus and human repair
cartilage tissues, and composition predicted using partial least squares analyses. Histology and immunohistochemistry
results were used as standards for validation. Infrared fiber optic probe spectral data were also obtained from meniscus (a
tissue with mixed collagen types) to evaluate the potential of this method for identification of collagen type in a minimally-
invasive clinical application. Concentration profiles of the tissue components obtained from multivariate analysis were in
excellent agreement with histology and immunohistochemistry results. Bone and tendon showed a uniform distribution of
predominantly type I collagen through the tissue. Normal cartilage showed a distribution of type II collagen and
proteoglycan similar to the known composition, while in repair cartilage, the spectral distribution of both types I and II
collagen were similar to that observed via immunohistochemistry. Using the probe, the outer and inner regions of the
meniscus were shown to be primarily composed of type I and II collagen, respectively, in accordance with
immunohistochemistry data. In summary, multivariate analysis of infrared spectra can indeed be used to differentiate
collagen type I and type II, even in the presence of proteoglycan, in connective tissues, using both imaging and fiber optic
methodology. This has great potential for clinical in situ applications for monitoring tissue repair.
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Introduction
Damage or degeneration of cartilage is frequently associated
with changes in the macromolecular structure and content of the
primary cartilage components [1], and can ultimately progress to
osteoarthritis (OA) [2]. The progression of OA has been directly
linked to the loss of proteoglycans (PGs) [3], and to changes in
collagen structure and orientation [4]. It is widely accepted that
cartilage injuries do not heal spontaneously [5], which is related to
the avascular nature of the tissue and the limited ability of mature
chondrocytes to proliferate and regenerate new cartilage [6].
Although there is no cure for OA, there have been advances in the
treatment of cartilage focal defects. Methods such as microfracture
and autologous chondrocyte implantation (ACI) can stimulate cells
to make extracellular matrix (ECM) components, and at times,
result in a spatial structure similar to normal cartilage [5,7].
Studies have shown that different modalities result in different
types of repair tissue. Microfracture generally results in fibrocar-
tilage which contains type I collagen [3], whereas following ACI, a
mixture of fibrocartilage and hyaline cartilage is generated [6].
The presence of hyaline cartilage, which is composed of type II
collagen, is better correlated with a positive clinical outcome [8–
10]. Type I and II collagen are among the fibril forming proteins
with a triple helical secondary structure in the collagen family,
however, there are some differences in their structure. The former
is a heterotrimer of COL1A1 and COL1A2 genes products, and
the latter is a homotrimer of COL2A1 gene products. Type I
collagen is usually incorporated with collagen type III and V, while
type II collagen is incorporated with type IX and XI collagens that
increase tissue load bearing properties and limit the fibril diameter
to smaller sizes compared to type I collagen. Type II collagen
contains a greater amount of hydroxylysine and glucosyl and
galactosyl residues than type I collagen, and these mediate the
connection of collagen and proteoglycan components in the
matrix [11]. Therefore, from a clinical perspective, knowledge of
the collagen type present in the repair tissue is extremely
important.
Currently, modalities to evaluate collagen quantity include
enzymatic digestion of the tissue followed by biochemical
hydroxyproline [12] or Sircol [13] assays. Evaluation of collagen
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type is typically performed by immunohistochemical (IHC)
analysis on thin tissue sections, or by tissue digest separation
methods such as high performance liquid chromatography
(HPLC) followed by collagen type detection by mass spectroscopy
(MS) [6,14,15]. These methods have different sensitivities to
collagen amount and type, but all can be time consuming and
require processing of the tissue. Fourier transform infrared (FT-IR)
spectroscopy is a powerful technique based on molecular
vibrations that has been widely used to assess biological tissue
composition [3,16–19]. FT-IR analysis relies on the unique
vibrational signature of the molecules present in the tissue, and
thus does not require the addition of an external contrast agent.
[20]. FT-IR can be utilized as a clinical tool when coupled with an
infrared fiber optic probe (IFOP) [21,22], or can be used for
analysis of harvested tissue when coupled with a microscope and
an array detector [3,16,23,24]. The latter modality, called FT-IR
imaging spectroscopy (FT-IRIS), creates ‘‘chemical’’ images of
tissues based on the absorbance of a specific molecular species at a
pixel resolution as high as 1.5 mm, in combination with
microscopic visualization of the samples [16]. FT-IRIS has been
increasingly used to characterize the structure, distribution, and
orientation of extracellular matrix molecules in histological
sections of cartilage and other connective tissues [16,25–27].
There is considerable overlap in the spectral signatures of
proteins in connective tissues, and therefore, it is not always
possible to identify a unique absorbance at a specific frequency
that is associated with a particular component. Univariate analyses
of IR spectra have been performed to evaluate collagen and
proteoglycan (PG) concentration [3,16,23,26–29]. Recent studies
have shown that application of second derivative spectra in
univariate analysis results in better measurement of matrix
component [30]. However, multivariate analysis techniques that
evaluate multiple frequencies of the spectra simultaneously are
increasingly used to improve specificity of the analysis and predict
matrix components quantitatively. Euclidean distance [31,32],
cluster analysis [24], and partial least squares (PLS) [21,33], have
all been used to analyze FT-IR spectra of cartilage. These studies
demonstrated the ability to distinguish normal, repair, young and
mature tissues, and to quantitatively analyze matrix components.
To date, however, discrimination of regions of type II collagen in
tissues with other collagen types by univariate or multivariate
analysis of FT-IR spectra has not been demonstrated.
The aim of the current study was to assess whether FTIR
spectroscopy, applied in both an imaging mode (to histological
sections) and fiber optic modality (to the tissue surface), can
differentiate collagen type I and II in connective tissues. A PLS
model was developed based on a library of IR spectra of varying
concentrations of pure tissue components including type I
collagen, type II collagen, and aggrecan (the primary PG in
cartilage). Assessment of the composition of tendon and bone
(primarily type I collagen), hyaline cartilage (primarily type II
collagen), repair cartilage (often a mix of types I and II collagen)
and meniscus (known to consist of both type I and II collagen) was
performed to validate the PLS model. In addition, multivariate
cluster analysis was performed to evaluate an alternate method for
discrimination of types I and II collagen in histological sections of
tissues. Finally, the model was validated on fiber optic probe data
acquired from an intact meniscus to demonstrate the potential of
this method for in vivo clinical use.
Materials and Methods
Overview
Infrared spectra were collected from mixtures of varying
amounts of pure type I and II collagen, and aggrecan to form a
spectral library. The spectral library was used to predict the
concentration of these components in histological sections of
connective tissues using FT-IRIS, and on the surface of meniscus
using IFOP assessment to show feasibility of this modality.
Pure components
Type I collagen, type II collagen, and aggrecan powders were
used to make mixtures that were analyzed as potassium bromide
(KBr) pellets. Two different sets of samples were prepared that
included mixtures of varying concentrations of type II collagen
(chick nasal articular cartilage, Genzyme, Boston, MA) and
aggrecan (calf nasal aggrecan, generously supplied by L. Rosen-
berg, Montefiore Hospital, Bronx, NY in a prior study [26])
(Model A), and mixtures of varying concentrations of type I
collagen (bovine skin, USB Corporation, Cleveland, OH) and type
II collagen (bovine articular cartilage, USB Corporation, Cleve-
land, OH) (Model B). Inclusion of type II collagen from two
different sources permitted us to assess the sensitivity of the
analysis to collagen source. Collagens and/or aggrecan were
mixed as 1% by weight with 100 mg KBr powder (International
Crystal Labs, Garfield, NJ) to create KBr pellets.
The composition of pellets for Model A (n = 10 pellets per
mixture) and Model B (n = 3 pellets per mixture) are summarized
in Table 1 and Table 2, respectively.
Bovine tissue
Bovine knee joints (2–3 weeks old) were obtained from a local
FDA approved abattoir (JBS Souderton, Souderton, PA). Cortical
bone was harvested from the tibia and cut into 16261 cm3
samples. The patellar tendon was harvested and cut into 2 cm2
pieces. Full depth cartilage, including the calcified cartilage layer,
was harvested from the medial and lateral femoral condyles (5 mm
diameter pieces). Lateral meniscus was harvested and cut in the
sagittal plane for FT-IRIS, and used intact for infrared fiber optic
probe (IFOP) spectroscopy. Bone and tendon were evaluated as
standards for tissues considered to have very little or no type II
collagen, while the articular cartilage matrix was considered a
standard for a tissue with very little or no type I collagen. Meniscus
was assessed as a model of a tissue that contains both type I and II
collagen in its matrix. All tissues were fixed in 10% buffered
formalin (Richard-Allan Scientific, Kalamazoo, MI) for 24 hours.
Bone and cartilage samples were decalcified in a 12.5% EDTA
solution. After formalin fixation, tissues were put into 70% ethanol
for dehydration prior to paraffin embedding. Paraffin blocks were
sectioned at 6 and 7 micron thickness on glass slides and low-
emissivity slides (low-e, Kevley Technologies, Chesterland, OH)
for histology and FT-IRIS, respectively. Tendons were sectioned
Table 1. The composition of pellets for Model A (n = 10
pellets per mixture).
Sample 1 2 3 4 5
Type II collagen (wt %) 0 25 50 75 100
Aggrecan (wt %) 100 75 50 25 0
doi:10.1371/journal.pone.0064822.t001
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longitudinally, and meniscus and articular cartilage sectioned
sagittally.
Human tissue
Full-depth core biopsy samples (1.8 mm in diameter) were
obtained from patients who had undergone autologous chondro-
cyte implantation (ACI) for a medial femoral condyle defect ,12
months previously (N= 4). All tissues were obtained under
approval of the NRES Research Ethics Committee (West
Midlands, UK). Participants provided their written informed
consent to participate in this study and the ethics committee
approved this consent procedure. The tissues were immediately
snap frozen and stored in liquid nitrogen until processed. Seven
micron thick sections were cut and collected for analyses as above.
Histological and immunohistochemical (IHC) analysis
Histologic sections of bone, tendon, meniscus and cartilage were
stained using hematoxylin & eosin (H&E) and Alcian blue (for PG
assessment) (Sigma-Aldrich, St. Louis, MO). Since both types I
and type II collagen are generally present in repair cartilage, IHC
images of the tissues were used as the gold standard for
comparison. IHC staining was performed on cryosections of
ACI biopsies using antibodies specific to type I and II collagen.
Separate tissue sections were incubated for 1 hour at room
temperature with primary antibodies against type I collagen
(monoclonal antihuman, clone no 1-8H5; ICN) and type II
collagen (CIICI; Developmental Studies Hybridoma Bank, IA)
[6]. Endogenous peroxidase was blocked with 0.3% hydrogen
peroxide in methanol before sections were incubated with the
biotinylated secondary anti-mouse antibody. The signal was
amplified using an avidin–biotin–peroxidase reagent (Vectastain
Elite ABC kit; Vector Laboratories, Peterborough, UK) and
labeling was visualized with diaminobenzidine as substrate.
Sections were then washed, dehydrated, and mounted in pertex.
‘Control’ sections of biopsy samples (to assess nonspecific antibody
binding) were treated either with normal mouse IgG, normal
rabbit serum, or phosphate buffered saline alone, in place of the
primary antibodies, and then treatment continued.
In addition, IHC staining of paraffin-embedded meniscus was
performed for type I collagen using a primary antibody against
type I collagen (anti-collagen type I, fetal mouse skin, Calbiochem,
Merck Milipore, Darmstadt, Germany).
FT-IR data acquisition
KBr pellets: FT-IR spectra from the Model A type II collagen
and aggrecan KBr pellets had been previously collected as
described in Camacho et al [26]. FT-IR spectra from the Model
B type I and type II collagen KBr pellets were collected in the mid-
IR region of 1800–900 cm21 at 4 cm21 spectral resolution using a
Spectrum 400 FT-IR spectrometer (Perkin Elmer, Shelton, CT).
The average time for data collection from each pellet was
,2 minutes.
FT-IRIS data collection: FT-IRIS data were acquired from this
sections of human and bovine tissues (n = 3 per tissue type) in the
mid-IR region, 1800–750 cm21 at 4 cm21 spectral resolution and
25 mm spatial resolution using a Spectrum SpotLight 400 FT-IR
Imaging system (Perkin Elmer, Shelton, CT). Depending on the
size of the tissue section (0.5–1.5 mm2), data collection time
ranged from ,5–20 minutes.
IFOP data collection: To validate the ability to discriminate
type I and type II collagen in intact tissues, infrared fiber optic
probe (IFOP) data were collected from bovine meniscus in the
mid-IR region of 1800-900 cm21 at 4 cm21 spectral resolution
with 256 co-added scans (average time of scan for each spectrum:
,1 minute), using a Bruker infrared spectrometer (Billerica, MA)
equipped with a mercury cadmium telluride (MCT) detector and
coupled to a chalcogenide fiber optic probe of ,6 mm diameter
(Remspec Corp, Charlton, MA) with a flat-tipped ZnS attenuated
total reflectance (ATR) crystal of 1 mm diameter. The 1 mm tip of
the probe was placed in direct contact at 90u to 24 individual
regions on the meniscus femoral surface for data acquisition.
Penetration of infrared radiation in IFOP data collection is
restricted to the tissue surface to a depth of ,10 microns [34].
Prior to multivariate analyses (described below), the spectral
regions of the amide I protein absorbance (1718–1594 cm21), the
amide II protein absorbance (1594-1492 cm21), and the PG sugar
ring absorbance (1140-985 cm21) were investigated to qualita-
tively assess component distribution in IR images [16].
Multivariate analysis (PLS)
FT-IR spectra obtained from KBr pellets of pure component
mixtures in the 1800-900 cm21 range were used to create PLS
models to validate that the spectra from these mixtures could
indeed be differentiated based on concentration of components.
This spectral range was chosen for analysis to correspond with the
spectral range in the IFOP data. PLS analysis was originally
developed based on regression analysis and principal component
analysis (PCA), where the scores calculated by projection of the
response and independent variables to a new space of principal
components are used to find a linear regression model and predict
unknown variables. PCA is a multivariate analysis method which is
used to reveal hidden structure within data and provide visual
representation of the relationship between variables and response.
It decomposes the information carried by the original variables
and projects them onto a smaller number of latent variables called
principal components (PCs). In PLS analysis, a model is found that
correlates PCs of the matrix of variables to PCs of the response
using linear regression analysis [35–38]. A multiplicative scatter
correction (MSC), second derivative differentiation with 13-point
Savitzky–Golay smoothing, and normalization to the maximum
peak height of all spectra were applied to optimize the models.
MSC is a signal processing method which is used to remove the
scattering and offset effects in the spectra [36]. IR spectra were
employed as variables with each spectral frequency input as an x
variable, and the actual type I collagen, type II collagen or PG
content used as the response variables. All spectral variables
(frequencies) were input with equal weighting. A leave-one-out
cross validation was used to create the PLS models. In this method
of validation, a repeated analysis is done on the data, where each
time one of the samples is left out and the PLS model is optimized
based on the remaining spectra, The model is then used on the left
out sample for validation [38,39]. The number of factors for the
model was calculated to be seven, based on the minimal residual
sum of squares error (SSerr) [35].
Based on a leverage versus residual scatter plot of the PLS
model [35], no outliers were detected in the PLS cross-validation
Table 2. The composition of pellets for Model B (n = 3 pellets
per mixture).
Sample 1 2 3 4 5
Type I collagen (wt %) 100 75 50 25 0
Type II collagen (wt %) 0 25 50 75 100
doi:10.1371/journal.pone.0064822.t002
Discrimination of Type I and II Collagen
PLOS ONE | www.plosone.org 3 May 2013 | Volume 8 | Issue 5 | e64822
models. The quality of the model was evaluated by assessment of
the root mean square error (RMSE), and the regression coefficient
(R2) of the cross validation model. RMSE measures the precision
of the model and is calculated according to the equation below:
RMSE~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
(Y Pr ediction(i){Y exp eriment(i))2
N
s
ð1Þ
(i: number of samples = 1 to N) [40,41].
Once the PLS model was developed from the pure component
KBr pellet data, the model was applied to the infrared spectra
collected from different regions of the connective tissues of interest
to predict composition. The number of FT-IRIS spectra collected
spanned the length of the tissue section analyzed so that, e.g., 100
spectra collected at 25 micron pixel resolution = 2500 microns
total length. The IR spectra included 100 FT-IRIS spectra of
cortical bone, 100 FT-IRIS spectra of tendon (transverse
direction), 80 FT-IRIS spectra of articular cartilage (from
superficial zone to deep zone), 100 FT-IRIS spectra of meniscus
(from the tip of inner region towards the outer region), and 24
IFOP spectra (1 mm region per spectrum) from the meniscus
surface, from the inner to outer region. The output for the PLS
model prediction is either percent dry weight of a specific
component (for the dehydrated tissue sections), or percent wet
weight (for the in situ meniscus fiber optic probe data). IHC
images of human repair cartilage were used to assess the repair
cartilage PLS model prediction result for regions composed of
hyaline (type II collagen with greater proteoglycan) and fibrocar-
tilage (type I collagen). In meniscus, IHC images and Alcian blue
staining were used as standard methods for assessment of type I
collagen and proteoglycan distribution, respectively.
Multivariate Analysis (Cluster analysis)
Cluster analysis of infrared imaging spectra has previously been
performed to qualitatively differentiate tissue types [24]. With this
method, regions of IR images are separated into two or more
classes, or ‘‘clusters’’, with similar spectral properties. A supervised
cluster analysis was performed in this study, where four libraries of
infrared spectra were created from spectra obtained from 1. FT-
IRIS images of bone (primarily type I collagen), 2. FT-IRIS
images of regions of cartilage repair tissue that were predomi-
nantly type I collagen, 3. FT-IRIS images of regions of cartilage
repair tissue that were predominantly type II collagen, and 4. KBr
pellets of pure aggrecan. The FT-IRIS spectral libraries were
obtained from one tissue section of an ACI repair biopsy. IR
spectra of type I and II collagen-rich regions from ACI repair
tissue were chosen to create the library, instead of using pure
component spectra, to assess the ability of the cluster analysis
technique to differentiate fibrocartilage-like type I collagen from
bone type I collagen. The libraries were then used to predict a
distribution map of these tissue types in independent samples of
repair cartilage (n = 3). Cluster analysis was performed using Fuzzy
C-means, with four initial centroids and a Fuzzy index equal to
3.3. All data analysis were performed using ISys v5.0 (Malvern
Instrument, Columbia, MD), and Unscrambler v10 (Camo,
Norway).
Results
PLS models
Pure Components. IR spectra of pure component KBr
mixtures (Models A and B) with varying type II collagen content
show progressive changes in height and area under the amide I
(1718–1594 cm21), amide II (1594–1492 cm21) and PG (1140-
985 cm21) absorbance bands (Figure 1A). Based on the broaden-
ing of the absorbance bands, it appeared that scattering was
evident in the spectra of the type I and type II collagen mixtures,
possibly due to incomplete grinding of the samples. Second
derivative and MSC spectral analysis reduced the scattering
artifact, and revealed more details on peak position (Figure 1B).
Although the type II collagen second derivative spectra in models
A and B (solid dark black lines) were not identical based on relative
peak heights, the peak positions were essentially equivalent
between the two models. There were small differences in several
second derivative peak positions (ranging from 4 to 8 cm21) of the
type I and type II collagen spectra (Figure 1B), including in the
amide I and II regions, in the side chain absorbance regions (near
,1400 and 1300 cm21), and in the glycosylation regions near
1100–1000 cm21, but for the most part, significant overlap in the
spectral frequencies precluded unique association of any peak
position with a collagen type. This clearly motivated a multivariate
analysis strategy for differentiation of these collagen types in
tissues. Differences among second derivative spectra for the
collagen and aggrecan mixtures were more obvious across the
entire frequency range.
Both PLS models showed a complete discrimination among
KBr pellet samples with varying composition (Figure 1C).
However, Model A showed discrimination of percentage of type
II collagen in both Factor 1 and Factor 2, while Model B showed
discrimination of percentages of type II collagen based on Factor
1. Therefore, when using Model B for assessment of the amounts
of type I and II collagen, only Factor 1 would be considered. PLS
analysis parameters, including percentage of variation of the
model explained by each factor, are summarized in Table 3.
Bone and Tendon Composition. Using Model B, FT-IRIS
images of cortical bone and tendon both were predicted to have a
fairly uniform distribution of type I collagen, with approximately
85% type I collagen (dry weight) in each tissue (Figure S1A and
S1B). Although both tissues are considered to have no type II
collagen, just under 5% of type II collagen was predicted in both
tissues. Given that the RMSE of the models is ,5%, this is within
expected limits.
Normal Articular Cartilage Composition
The superficial, middle, deep, and calcified cartilage zone were
visualized in the FT-IRIS images from articular cartilage based on
total protein (Amide I) (Figure 2A). This is the expected normal
zonal structure of articular cartilage. The PLS model prediction
showed that type II collagen and PG content varied through the
thickness of the cartilage, with PG concentration increasing from
the superficial to middle and deep zones (Figure 2B). The deep
zone contained the highest type II collagen concentration, ,80%
dry weight, and the calcified cartilage zone contained the lowest
type II collagen concentration, ,55%. Similar concentration
profiles from the superficial to calcified zone were found using
models A and B (Figure 2C, 2D).
Human Cartilage Repair Tissue Composition. Excellent
agreement was seen between type I collagen, type II collagen and
PG content predicted in the FT-IRIS images by the PLS models,
and the component distributions as visualized in the IHC and
histology images (Figure 3A, B, C, D, F, I). Less than 5% type II
collagen was predicted in subchondral bone, likely due to error in
the model (Figure 3B). Similar to the PLS results of this tissue
section, cluster analysis on the FT-IRIS image showed greater
hyaline cartilage (type II collagen rich) in deeper regions of repair
tissue, while type I collagen rich matrix was found throughout the
repair tissue, but not in the bone (Figure 3E, G, H, J). However,
Discrimination of Type I and II Collagen
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Figure 1. PLS score plots of pure component mixtures. Baselined infrared spectra (A), 2nd derivative spectra (B) and PLS score plots of pure
component mixtures in KBr pellets for Model A (mixtures of type II collagen and aggrecan) and Model B (mixtures of type I and type II collagen).
Progressive changes in IR spectra with type II collagen variation can be seen. Asterisks in Figure 1B denote regions where second derivative spectra
do not overlap. Mixtures with different compositions are completely distinguished in the PLS models.
doi:10.1371/journal.pone.0064822.g001
Table 3. Parameters of PLS models used to predict component concentration.
R-squared RMSE (%)
% of variation
explained by Factor 1
(variables)
% of variation
explained by Factor 1
(response)
% of variation
explained by Factor 2
(variables)
% of variation
explained by Factor
2 (response)
Model A 0.97 4.36 74% 77% 25% 22%
Model B 0.98 4.88 65% 94% 18% 2%
doi:10.1371/journal.pone.0064822.t003
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there were some differences between the type I collagen and type
II collagen distribution maps in the FT-IRIS images derived from
cluster analysis, and the corresponding IHC images. This is likely
due to the fact that the library of spectra utilized for the supervised
cluster analysis were not necessarily pure components of type I or
type II collagen, but were obtained from regions in FT-IRIS
images that were primarily type I or type II collagen (as described
in the Methods section). However, bone tissue type I collagen was
only detected in the confirmed bone regions of the FT-IRIS
images of the ACI biopsy, and not within the cartilaginous tissue.
PG co-distributed primarily with the type II collagen rich regions,
as expected.
Meniscus Composition. FT-IRIS Data: Both PLS models
predicted that the inner region of the meniscus tissue section
contained greater quantities of type II collagen compared to the
outer region (Figure 4A and 4B). Conversely, less type I collagen
was predicted in the inner region compared to the outer, which
was confirmed by type I collagen IHC (Figure 4C). In addition,
proteoglycan concentration was also predicted to be greater in the
inner region relative to the outer regions. This was confirmed by
the Alcian blue staining (Figure 4D).
IFOP Data: Analysis of the intact meniscus surface by IFOP
showed a similar result to that obtained with the PLS analysis of
the meniscus tissue sections (Figure 5), where the inner region
surface was predicted to contain more type II collagen and PG
compared to the outer region surface. There were small, non-
linear fluctuations in the amount of these components observed
from the medial to more lateral regions, e.g. among spectra 19–26,
but the fluctuations were within the approximate error of
prediction of the model, ,5%, so it’s not clear whether the
variations are indeed meaningful. In these in situ surface studies,
type II and type I collagen content was found to be relatively lower
compared to what was found in the meniscus tissue sections. This
is likely due to the fact that the intact tissue is sampled wet, and
thus we obtain a wet weight percentage, as opposed to the dry
weight percentage obtained from the dehydrated tissue sections.
However, the predicted PG content was not noticeably lower for
the surface IFOP measurements (wet weight) compared to the FT-
Figure 2. Articular cartilage matrix component concentration profile predicted using PLS models. Total protein amide I FT-IR image,
where the color bar indicates the relative protein concentration as lower concentration (blue) through higher concentration (red), and Alcian blue
histology image of articular cartilage (A). FT-IRIS data were collected from the articular surface to the subchondral bone, with the positions of data
collection indicated on the IR image. Each position corresponds to a 25 micron region of data collection. PG (Panel B) and type II collagen (Panels C,
D) concentration profiles in normal articular cartilage predicted using PLS models A (Panel D) and B (Panel C) (representative data shown for one
sample). The Alcian blue-stained histology image shows the qualitative PG distribution, which is slightly higher in the deep zone, and similar to that
predicted using Model A. Models A and B predicted similar distributions of type II collagen, where the deep zone contains a greater amount
compared to the superficial and middle zones.
doi:10.1371/journal.pone.0064822.g002
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IRIS image data from the thin section (dry weight). Thus, it is
possible that the PG content on the meniscus surface is indeed
different from that sampled from the center of the meniscus in the
FT-IRIS image.
Discussion
The current study demonstrates the ability to discriminate
collagen types I and II based on spectral data for the first time.
Comparison of spectral results with immunohistochemical data,
the gold standard for differentiation of collagen types in tissue
sections, confirms that this spectral approach can be used for semi-
quantitative assessment of tissues with mixed collagen types.
Further, IFOP data obtained from intact meniscus also discrim-
inated regions of type I and type II collagen in that tissue.
Assessment of collagen types in histological tissue sections is
most commonly done using IHC techniques. There have been
Figure 3. Repair cartilage matrix component concentration profile predicted using PLS models. Type I collagen (A), type II collagen (B),
and PG (C) content of repair cartilage predicted by the PLS models show greater type II collagen is found in regions adjacent to bone (representative
data shown for one sample). Each position corresponds to a 25 micron region of data collection. Cluster analysis-derived IR images show type I
collagen (from repair cartilage spectral library), (E), type II collagen (from repair cartilage spectral library), (G), PG (from aggrecan spectral library), (H),
and type I collagen (from bone spectral library), (J), distribution in repair cartilage and subchondral bone. IHC images of type I (D) and II (F) collagen
and Alcian blue histology image (I) are used for comparison. Cluster analysis was done using Fuzzy C-means with four centroids defined. Higher
values on the cluster analysis images scale show a closer distance to the corresponding centroid (tissue type). In the type II collagen IHC image,
darker areas shows regions with more type II collagen (hyaline cartilage) and lighter areas indicate the presence of fibrocartilage-like tissue.
doi:10.1371/journal.pone.0064822.g003
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many studies over the last 30 years that have performed IHC for
evaluation of the types of collagen present in connective tissues,
but of particular interest is the distribution of collagen types in
cartilage repair tissue as a correlate to the quality of the tissue, as
shown in [6,7,42]. However, immunohistochemical analysis has
several limitations, including the dependence of the outcomes on
the experience of the investigator [43]. It was also shown that
choice of antibody panel and the interpretation of the reaction
patterns are important factors in the ability to obtain reliable
results and improve the sensitivity and specificity of the reaction
[44]. These limitations motivate our studies to develop an
alternative method to distinguish collagen types which would be
a more objective and less bias-prone approach.
The spectral similarities between type I and type II collagen
preclude evaluation of these collagen types based on one single
spectral absorbance. Even though subtle differences among
spectra were observed at several frequencies by evaluation of
second derivatives, it was not possible to attribute these differences
to specific features of the collagen molecules. Shifts in absorbance
frequencies can occur if collagen molecules are in different
hydration environments, or bound to different non-collagenous
proteins, as is the case for type I and type II collagen. Thus,
multivariate analyses, where many frequencies are utilized, have
been explored. Several studies have shown that processing of FT-
IR spectra using multivariate analysis methods provides quanti-
tative information related to cartilage and bone tissue quality.
Potter et al. utilized Euclidean distance analysis of IR imaging
spectra obtained from histological sections to map collagen and
chondroitin sulfate content of bovine nasal cartilage and
engineered cartilage based on comparison to IR spectra of pure
components [31]. Euclidean distance analysis has also been
performed on IR spectra obtained from different collagen types
in pure proteins [45], histological sections of human [32] and steer
[27] cartilage to assess the relative concentration of collagen or PG
in those tissues. Rieppo et al. performed cluster analysis to
differentiate porcine cartilage repair tissue from normal articular
cartilage [24], and Kobrina et al used this technique to
differentiate histological zones in intact articular cartilage [46].
PCA analysis of FT-IR spectra was used by Yin et al to evaluate
collagen and proteoglycan content of articular cartilage [47]. PLS
analysis has been performed to assess the matrix constituents of
engineered cartilage [33], proteoglycan content of articular
Figure 4. Meniscus histological section component concentration profile predicted using PLS models. Meniscus matrix composition
prediction: FT-IRIS data obtained from a histological section, and predicted using PLS Model A (A) and B (B) (representative data shown for one
sample). The inner region shows more PG and type II collagen compared to the outer region. The IHC image of type I collagen (C), and the Alcian blue
histology image (D) show type I collagen and PG distribution respectively, which are in agreement with the predicted type I collagen and PG
concentration, respectively. Each position corresponds to a 25 micron region of data collection.
doi:10.1371/journal.pone.0064822.g004
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cartilage [48], and cartilage degeneration using a fiber optic probe
[21]. In the aforementioned studies, although the multivariate
analyses permitted semi-quantitative assessment of differences in
proteoglycan, specific analysis of type II collagen in tissues with
other collagen types (e.g. repair cartilage) was not performed.
There are several potential sources of error in the current
studies, including technical errors, such as Beer’s law non-linearity,
instrumental misalignment, inaccurate weighing of the pure
component samples, and scattering in the KBr pellets [41], which
may have contributed to broadening of the peak positions in the
Model B spectra. However, similar results for prediction of type II
collagen in tissues were obtained with both Models A and B,
indicating that the spectral artifacts did not interfere significantly
with the analyses. Errors could also arise from ignoring the
contribution of small quantities of non-collagen or non-proteogly-
can matrix component (such as glycolipids or glycoproteins) and
cells, and using aggrecan with no link protein and hyaluronic acid
as representative of proteoglycan in all tissues. In addition, the
structure of the type I and II collagen powders used in the
standard pellets is different from that of native collagen found in
biological tissues with respect to lack of interactions with other
matrix components, and possible differences in crosslinking, which
can also result in errors in the models developed. Nonetheless our
results showed that IR spectra collected from type I and II collagen
pellets are similar enough to IR spectra of bone/tendon (type I
collagen) and normal hyaline cartilage (type II collagen),
respectively, for prediction in multivariate models. In the cluster
analysis, the IR spectral library was generated based on type I and
II collagen of ACI cartilage, as opposed to pure component
spectra. The regions where the type I and type II collagen spectra
were extracted from were chosen based on IHC identification of
collagen type. However, as previously discussed, IHC analysis also
has limitations regarding specificity. Further, the regions chosen
for extraction of type I and type II collagen spectra also no doubt
had other components present in small quantities, which would
contribute to the errors in the models developed.
The variation in type II collagen content predicted by both
models for normal cartilage was in a good agreement with the IR-
derived collagen distribution shown in Figure 2A. Collagen
content reached a maximum of ,80% in the deep zone, which
is also in agreement with the reported approximate relative
amount of dry weight collagen concentration in articular cartilage
[4]. The type II collagen quantity was at a minimum in the
calcified cartilage zone, which could reflect the presence of type X
Figure 5. Intact meniscus component concentration profile predicted using PLS models. Type II collagen (A), PG (B) and type I collagen (C)
content of lateral meniscus predicted using PLS analysis of IFOP spectra collected from the intact tissue (Model A used for panels A and B, and Model
B used for panel C). Each position corresponds to a 1 mm diameter region of IFOP data collection. Similar to the results obtained for the analysis of
meniscal tissue by IR imaging, the inner region was predicted to contain a higher concentration of type II collagen compared to the outer region.
Each position corresponds to a 1 mm sampling region by IFOP.
doi:10.1371/journal.pone.0064822.g005
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collagen as the primary protein in this region [49], although we
did not include type X collagen measurements in the current
study. The predicted amount of proteoglycan (aggrecan) and type
II collagen combined was ,90% of the matrix dry weight
throughout the superficial to deep zones which is also similar to
what has been reported previously [1]. The type II collagen
quantity measured using Models A and B, which contained
different sources of type II collagen, resulted in similar composi-
tional variations throughout the tissue depth. It is important to
note that these measurements are semi-quantitative, reflecting
percentage of a type of collagen, and not a fully quantitative
assessment. However, these data confirm that the methods
developed are not sensitive to collagen source.
A positive clinical outcome in ACI procedures has been
correlated with the amount of hyaline repair tissue [10,50,51],
whereas the presence of fibrocartilage with little hyaline cartilage
has been linked to failure of the treatment [51]. In our previous
study, we demonstrated that FT-IRIS data obtained from ACI
biopsies were equivalent to histologic or IHC parameters for
prediction of clinical outcome based on the Lysholm score [10].
The results from the current study augment those findings by
specifically assessing collagen type with FT-IR, and thus provide
another non-destructive, measure of tissue quality. Potential
clinical application was further shown by assessment of collagen
type and PG distribution in bovine meniscus in both imaging data
and in fiber optic data. Results were in agreement with previous
immunostaining studies, including evaluation of rabbit [52] and
human meniscus [53], where it was confirmed that type II collagen
is primarily localized at the interior site of the medial meniscus.
Notwithstanding these positive results, a limitation of the mid-
infrared fiber optic studies is that penetration is restricted to ,10
microns below the tissue surface, and thus only superficial
components are evaluated. In the current study, however, this
sampling modality was sufficiently sensitive for evaluation of the
distribution of matrix components in the intact tissue, as it was
shown in our previous study [54].
Although mid-infrared fiber optic spectroscopic analysis has not
yet been used clinically for evaluation of cartilage repair tissue or
meniscus, it has been used to assess cartilage degeneration [21,33].
The application of a mid-infrared fiber optic probe to evaluate
degenerative cartilage in harvested human tissues was shown in
earlier studies from our lab, [21,54], where a PLS analysis method
was used to correlate spectral data acquired from an IFOP to the
visual score [21], and histological score [54] for degenerative
cartilage. We showed that the PLS model developed based on
infrared fiber optic probe spectroscopy data was able to predict the
histological grade of degenerative tissue comparably to histological
Mankin score, the gold standard of such analysis. In addition, Bi et
al. evaluated disease progression in an OA rabbit model, using a
PLS model based on IFOP data obtained from femoral cartilage
[55].
Nevertheless, there would be some limitations in translation of
this methodology to predict collagen type in a clinical application.
Since the current configuration of the ATR probe crystal has a
1 mm diameter, this is the smallest tissue region that can be
evaluated. While this still may be sufficient for assessment of repair
of a tissue lesion, newer fiber optic configurations are being
developed with smaller sampling capability. Our previous study
demonstrated that data collected from cartilage surface reflects the
tissue quality and degree of degeneration [54], which could be
useful in clinical procedures where definition of the margins of a
lesion are required. However, it remains to be confirmed whether
this is the case for repair tissue as well, and whether surface
measurements reflect full depth tissue quality. Another potential
limitation during in vivo assessment is interference from absor-
bances present in synovial fluid and blood. These may overlap
with absorbances from the proteins in cartilage, and have to be
taken into account with development of multivariate models.
Although the current studies performed did not address these
potential concerns in data analysis, future studies will focus on
these issues.
Together, the results of the current and earlier studies lay the
foundation for in situ evaluation of cartilage repair tissue and
meniscus repair using minimally-invasive infrared spectroscopy.
The use of an IR probe to evaluate tissue composition
arthroscopically for determination of quality without the need
for tissue harvest could significantly augment clinical management
of degenerative cartilage diseases and efficacy of related thera-
peutic interventions.
Supporting Information
Figure S1 Type I and type II collagen concentration
profile in bone (Panel A) and tendon (Panel B) predicted
using PLS model B (representative data shown for one
sample). The positions of FT-IRIS data collection are indicated
on the IR image. Each position corresponds to a 25 micron region
of data collection.
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